Robinson et al. reported results in 188 patients with lymphoma [low-grade NHL n = 52, high-grade NHL

(n = 62), Hodgkin's disease (n = 52), and mantle cell lymphoma (n = 22)] who received various reduced-intensity conditioning regimens or nonmyeloablative HCT in EBMT-affiliated centers.46 The median age was 40 (range 2-61) years, and the median number of prior treatment courses was 3 (range 0-6). Forty-eight percent of patients had undergone prior autologous transplantation. The 1-year probability of TRM was 25.5%. The 1-year probability of progression-free survival was 46%, and was significantly better in patients with chemosensitive disease, Hodgkin's disease, and low-grade NHL.

0 0

Post a comment